Reference,Reference: DOI,Assay,Section,Pre-vaccine Infection,Vaccine,# Shots,Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,580.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,547.0,1.0,=,1.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1454.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,1134.0,1.0,=,1.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1582.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,1572.0,1.0,=,1.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2180.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,1878.0,1.0,=,1.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2340.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,779.0,1.0,=,3.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,2881.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,2344.0,1.0,=,1.2
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,3943.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,3999.0,1.0,=,1.0
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,608.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,783.0,1.0,=,0.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,625.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,695.0,1.0,=,0.9
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,893.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,1053.0,1.0,=,0.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,912.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,729.0,1.0,=,1.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1177.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,1062.0,1.0,=,1.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1190.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,885.0,1.0,=,1.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1309.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,1689.0,1.0,=,0.8
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Supplementary Figure S2A,None,BNT162b2,2,1m,Human,Wild Type (B.1),=,1357.0,1.0,L452Q + F490S,452,L452Q + F490S,1,=,826.0,1.0,=,1.6